Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Flaherty

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|May 6, 2026
Ca<sup>2+</sup>/calmodulin-dependent inhibitors of adenylyl cyclase 1 as novel nonopioid analgesics for chronic inflammatory painTiffany S Dwyer, Annadka Shrinidhi, Sadikshya Aryal, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Structural Characterization of Thiadiazolesulfonamide Inhibitors Bound to <i>Neisseria gonorrhoeae</i> α-Carbonic AnhydraseAnil Kumar Marapaka, Alessio Nocentini, Molly S Youse, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of <i>Neisseria gonorrhoeae</i>Nader S Abutaleb, Ahmed E M Elhassanny, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 23, 2023
Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamatesSimone Giovannuzzi, Anil Kumar Marapaka, Nader S Abutaleb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-activity relationship studies for inhibitors for vancomycin-resistant <i>Enterococcus</i> and human carbonic anhydrasesWeiwei An, Katrina J Holly, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|March 10, 2022
Optimization of a Pyrimidinone Series for Selective Inhibition of Ca<sup>2+</sup>/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic PainJason A Scott, Monica Soto-Velasquez, Michael P Hayes, et al.
European Journal of Medicinal Chemistry|April 23, 2025
Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococciAndrea Ammara, Simone Giovannuzzi, Alessandro Bonardi, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1Aaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2014
Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffoldDaniel P Flaherty, Denise S Simpson, Melissa Miller, et al.
Chembiochem : a European Journal of Chemical Biology|August 27, 2019
Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based InhibitorAaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|May 6, 2026
Ca<sup>2+</sup>/calmodulin-dependent inhibitors of adenylyl cyclase 1 as novel nonopioid analgesics for chronic inflammatory painTiffany S Dwyer, Annadka Shrinidhi, Sadikshya Aryal, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Structural Characterization of Thiadiazolesulfonamide Inhibitors Bound to <i>Neisseria gonorrhoeae</i> α-Carbonic AnhydraseAnil Kumar Marapaka, Alessio Nocentini, Molly S Youse, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of <i>Neisseria gonorrhoeae</i>Nader S Abutaleb, Ahmed E M Elhassanny, Alessio Nocentini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 23, 2023
Inhibition of pathogenic bacterial carbonic anhydrases by monothiocarbamatesSimone Giovannuzzi, Anil Kumar Marapaka, Nader S Abutaleb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 27, 2022
Structure-activity relationship studies for inhibitors for vancomycin-resistant <i>Enterococcus</i> and human carbonic anhydrasesWeiwei An, Katrina J Holly, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|March 10, 2022
Optimization of a Pyrimidinone Series for Selective Inhibition of Ca<sup>2+</sup>/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic PainJason A Scott, Monica Soto-Velasquez, Michael P Hayes, et al.
European Journal of Medicinal Chemistry|April 23, 2025
Redesigning oxazolidinones as carbonic anhydrase inhibitors against vancomycin-resistant enterococciAndrea Ammara, Simone Giovannuzzi, Alessandro Bonardi, et al.
Molecules (Basel, Switzerland)|March 6, 2021
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1Aaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2014
Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffoldDaniel P Flaherty, Denise S Simpson, Melissa Miller, et al.
Chembiochem : a European Journal of Chemical Biology|August 27, 2019
Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based InhibitorAaron D Krabill, Hao Chen, Sajjad Hussain, et al.
Pageof 6